-
Researchers move a step closer toward universal flu vaccine and therapies
Researchers describes three human antibodies that provide broad protection against Influenza B virus strains; the same team had previously reported finding broadly neutralizing antibodies against Influenza A strains; the work is a key step toward “universal” vaccine and therapies against flu
-
-
Deadly E. coli strain decoded
The secret to the deadly 2011 E. coli outbreak in Germany has been decoded; the deadliest E. coli outbreak ever, which caused fifty-four deaths and sickened more than 3,800 people, was traced to a particularly virulent strain that researchers had never seen in an outbreak before
-
-
Demystifying viruses' copying mechanism allows new vaccines for elusive viruses
Certain kinds of viruses such as those that cause the common cold, SARS, hepatitis, and encephalitis, copy themselves using a unique mechanism, according to researchers; the discovery sheds light on a previously identified, but never-before-understood region of an enzyme associated with the process of replicating genetic material
-
-
Poultry vaccines found to combine into new viruses
Researchers found that two different vaccine viruses — used simultaneously to control the same condition in chickens — have combined to produce new infectious viruses, prompting early response from Australia’s veterinary medicines regulator
-
-
A world free of foot-and-mouth disease within sight
The Departments of Homeland Security and Agriculture have developed a novel vaccine for one of the seven strains of the dreaded foot-and-mouth disease (FMD), paving the way for the development of the others; FMD is one of the most economically devastating diseases in the world for those who raise cows, sheep, pigs, goats, deer, and other cloven-hoofed animals is foot-and-mouth disease
-
-
Improving malaria control and vaccine development
Each year more than 250 million people worldwide contract malaria, and up to one million people die; malaria is particularly dangerous for children under five and pregnant women; Plasmodium falciparum is the most lethal of the four Plasmodium species, and is responsible for most clinical disease
-
-
Expanding the reach of an innovative virus-tracking software
SUPRAMAP is a Web-based application which synthesizes large, diverse datasets so that researchers can better understand the spread of infectious diseases across hosts and geography; researchers have restructured this innovative tracking software to promote even wider use of the program around the world
-
-
Bacteria's strength in numbers challenged
Scientists have opened the way for more accurate research into new ways to fight dangerous bacterial infections by proving a long-held theory about how bacteria communicate with each other
-
-
New plan would control deadly tsetse fly
The tsetse fly is an African killer that spreads “sleeping sickness” disease among humans and animals and wipes out $4.5 billion in livestock every year; the tsetse, which feeds on the blood of vertebrate animals, lives in thirty-seven sub-Saharan countries and infects thousands of people and millions of cattle every year
-
-
Early detection of malaria saves lives
The timely diagnosis of malaria maximizes the likelihood of successful, life-saving treatment; it also minimizes the chances that inappropriate therapy will be given, which would help combat the growing problem of drug resistant malaria
-
-
Bacteria found in caves could offer key to new antibiotics
Resistance to antibiotics among bacteria is a growing concern for human health; antibiotic-resistant bacteria found in one of the deepest, most isolated caves in the world could help scientists in the battle against superbugs
-
-
New technology sheds light on viruses
Scientists develop diagnostic tests that rapidly detect disease-causing viruses in animals and humans; the scientists using a new technology called surface-enhanced Raman scattering, or SERS
-
-
Handheld plasma flashlight rids skin of pathogens
Scientists develop a handheld, battery-powered plasma-producing device that can rid skin of bacteria in an instant; the device could be used in ambulance emergency calls, natural disaster sites, military combat operations, and many other instances where treatment is required in remote locations
-
-
Inovio Pharmaceuticals gets DoD continuation grant for synthetic DNA vaccine delivery device
The U.S. Department of Defense has given a Small Business Innovation Research grant to Inovio Pharmaceuticals to continue developing a low-cost, non-invasive surface electroporation (EP) delivery device; the testing of the device in conjunction with Inovio’s synthetic DNA vaccines against viruses with bioterrorism potential, including hanta, puumala, arenavirus and pandemic influenza
-
-
Detection technology detects viruses, pathogens within 24 hours
New detection technology could enable food safety professionals, law enforcement, medical professionals, and others to detect within twenty-four hours any virus or bacteria that has been sequenced and included among the array’s probes
-